Who we are:
Aquila BioMedical is a preclinical contract research organization that offers clients renowned research expertise within a quality-controlled environment, reducing the time and cost associated with drug development.
We have developed novel technologies to help you better understand the cellular and molecular events that occur with compound administration. These technologies enable you to identify hits more rapidly to optimise target selection before in life efficacy testing. We can provide you with mode-of-action data in the areas of:
What we do:
Aquila will work closely with you to understand your scientific needs and design the most appropriate research projects to optimise your drug development program. Aquila is dedicated to providing high quality scientific services through active communication and ultimately reducing project timelines.
We provide sophisticated research services to a range of clients, whether you are Pharma, CRO, Biotech, or academic. For information on our work in disease areas outside of those detailed above, please contact us.